Bluebird Bio

$83.8M revenue • 201 employees

Last Updated Oct 31, 2025

Company Overview

Company Name

Bluebird Bio

Approx. Annual Revenue

$83.8M

Employees

201

Established

2010

About Bluebird Bio

Bluebird bio is a gene therapy company with approximately 201 employees. They are setting the standard for gene therapy, with a focus on developing treatments for beta-thalassemia, cerebral adrenoleukodystrophy, and sickle cell disease. Bluebird bio has the largest and deepest ex-vivo gene therapy data set and is continuously improving and advancing their research and therapies.

Frequently Asked Questions about Bluebird Bio

Technologies Used

Social Profiles

Key Decision Makers

Hans Bitter Director
Andrew Obenshain Chief Executive Officer
Pooja Satija Associate Director Clinical Operations
LinkedIn
Brooke Orr Program Lead, Clinical Trial Strategy and Execution
LinkedIn